Published mark

Boston Scientific

BOSTON SCIENTIFIC CORP

NYSE: BSX. Canonical company identity and public leadership record.

US

Record source reportedRecord not claimedNo Eval published
Follow companySave PDF
Alpha ID
alpha:company:c74e3454-c7a5-426f-b315-da986196b6e2
SEC CIK
0000885725
Website
www.bostonscientific.com Open
Record version
vpublic-1:d751713988987e9331980363e24189ce:ro-d751713988987e9331980363e24189ce, published Oct 15, 2026
Newest evidence
Mar 18, 2026
Monitoring
Not yet monitored Details
Integrity
Not yet signed Methodology
CEO
Michael F. MahoneySince Mar 18, 2026
Chair
Not publishedLead independent: Eric Ludwig
Independent
9 / 1010 directors published
Published claims
464 distinct sources
Evidence records
100 pinned
Source conflicts
0None open

Built from 4 distinct sources and 10 evidence records. Every Claim links to where it appears. Where nothing was published, the record states the coverage gap.

CorroboratedSource reportedAlpha inferenceNot disclosed

Public record. Alpha publishes governance facts about this organization from regulatory filings and company statements. Private enterprise overlay data is never projected here. The company can claim the record, correct, or dispute any Claim. How this works

EXECUTIVE APPOINTED

Arthur C. Butcher executive of Boston Scientific, effective 2026-03-18.

EffectiveEffective Mar 18, 2026E4

Monitoring

Continuous

What the published record states about identity, evidence, evaluation, monitoring, authority, and freshness. Watched-source schedules are not published for this record.

  • Identityunclaimed
    Published
  • Evidencesource_reported
    Published
  • Evaluationnot_evaluated
    Published
  • MonitoringNot yet published for this record.
    Not published
  • AuthorityNot yet published for this record.
    Not published
  • Freshnesscurrent
    Published

Leadership

Evidence
RolePersonSinceStatusClaim
Executive Vice President and Group President, MedSurg and Asia PacificArthur C. ButcherMar 2026currentSource reportedE4
Executive Vice President and Chief Financial OfficerJonathan R. MonsonMar 2026currentSource reportedE5
Executive Vice President and Group President, CardiovascularJoseph M. FitzgeraldMar 2026currentSource reportedE6
Chairman of the Board, President and Chief Executive OfficerMichael F. MahoneyMar 2026currentSource reportedE7
Executive Vice President, General Counsel and Corporate SecretaryVance R. BrownMar 2026currentSource reportedE8

Board of directors

Evidence

10 directors published. 9 of 10 with a published determination are independent.

DirectorStatusSinceCommitteesClaim
Cathy R. SmithIndependent2026AuditAudit; Nominating and GovernanceNominating and GovernanceSource reportedE3
Cheryl PegusIndependent2024Executive Compensation and Human ResourcesExecutive Compensation and Human Resources; Risk, Science and Technology · ChairRisk, Science and Technology, chairSource reportedE3
Christophe P. WeberIndependent2026Executive Compensation and Human ResourcesExecutive Compensation and Human Resources; Risk, Science and TechnologyRisk, Science and TechnologySource reportedE3
David C. HabigerIndependent2024AuditAudit; Executive Compensation and Human ResourcesExecutive Compensation and Human ResourcesSource reportedE3
David S. WichmannIndependent2021Audit, chairAudit · Chair; Risk, Science and TechnologyRisk, Science and TechnologySource reportedE3
Ellen M. ZaneIndependent2016Executive Compensation and Human Resources, chairExecutive Compensation and Human Resources · Chair; Nominating and GovernanceNominating and GovernanceSource reportedE3
Eric LudwigIndependentLead Independent2014AuditAudit; Nominating and GovernanceNominating and GovernanceSource reportedE3
Jessica L. MegaIndependent2023Executive Compensation and Human ResourcesExecutive Compensation and Human Resources; Risk, Science and TechnologyRisk, Science and TechnologySource reportedE3
Michael F. MahoneyNot independent2012None publishedSource reportedE3
Susan E. MoranoIndependent2023AuditAudit; Nominating and Governance · ChairNominating and Governance, chairSource reportedE3

Committees and risk ownership

Evidence
CommitteeChairMembersRisks assigned
AuditDavid S. WichmannDavid S. Wichmann, Cathy R. Smith, David C. Habiger, Eric Ludwig, Susan E. MoranoNot described in the published record
Audit · Chair; Risk, Science and TechnologyNot publishedDavid S. WichmannNot described in the published record
Audit; Executive Compensation and Human ResourcesNot publishedDavid C. HabigerNot described in the published record
Audit; Nominating and GovernanceNot publishedCathy R. Smith, Eric LudwigNot described in the published record
Audit; Nominating and Governance · ChairNot publishedSusan E. MoranoNot described in the published record
Executive Compensation and Human ResourcesEllen M. ZaneEllen M. Zane, Cheryl Pegus, Christophe P. Weber, David C. Habiger, Jessica L. MegaNot described in the published record
Executive Compensation and Human Resources · Chair; Nominating and GovernanceNot publishedEllen M. ZaneNot described in the published record
Executive Compensation and Human Resources; Risk, Science and TechnologyNot publishedChristophe P. Weber, Jessica L. MegaNot described in the published record
Executive Compensation and Human Resources; Risk, Science and Technology · ChairNot publishedCheryl PegusNot described in the published record
Nominating and GovernanceSusan E. MoranoSusan E. Morano, Cathy R. Smith, Ellen M. Zane, Eric LudwigNot described in the published record
Risk, Science and TechnologyCheryl PegusCheryl Pegus, Christophe P. Weber, David S. Wichmann, Jessica L. MegaNot described in the published record
Committee RecordAudit: Chair David S. Wichmann; Members David S. Wichmann (Chair); Cathy R. Smith; David C. Habiger; Eric Ludwig; Susan E. Morano
Committee AppointmentDavid S. Wichmann: chair, Audit
Committee AppointmentCathy R. Smith: member, Audit
Committee AppointmentDavid C. Habiger: member, Audit
Committee AppointmentEric Ludwig: member, Audit
Committee AppointmentSusan E. Morano: member, Audit
Committee RecordExecutive Compensation and Human Resources: Chair Ellen M. Zane; Members Ellen M. Zane (Chair); Cheryl Pegus; Christophe P. Weber; David C. Habiger; Jessica L. Mega
Committee AppointmentEllen M. Zane: chair, Executive Compensation and Human Resources
Committee AppointmentCheryl Pegus: member, Executive Compensation and Human Resources
Committee AppointmentChristophe P. Weber: member, Executive Compensation and Human Resources
Committee AppointmentDavid C. Habiger: member, Executive Compensation and Human Resources
Committee AppointmentJessica L. Mega: member, Executive Compensation and Human Resources
Committee RecordNominating and Governance: Chair Susan E. Morano; Members Susan E. Morano (Chair); Cathy R. Smith; Ellen M. Zane; Eric Ludwig
Committee AppointmentSusan E. Morano: chair, Nominating and Governance
Committee AppointmentCathy R. Smith: member, Nominating and Governance
Committee AppointmentEllen M. Zane: member, Nominating and Governance
Committee AppointmentEric Ludwig: member, Nominating and Governance
Committee RecordRisk, Science and Technology: Chair Cheryl Pegus; Members Cheryl Pegus (Chair); Christophe P. Weber; David S. Wichmann; Jessica L. Mega
Committee AppointmentCheryl Pegus: chair, Risk, Science and Technology
Committee AppointmentChristophe P. Weber: member, Risk, Science and Technology
Committee AppointmentDavid S. Wichmann: member, Risk, Science and Technology
Committee AppointmentJessica L. Mega: member, Risk, Science and Technology

Control and voting power

Evidence

No published claims

Nothing is published for this section yet. A missing Claim is a coverage state, not a negative finding.

Authority to act

Evidence and agent registry

Who can act for the company, and on whose authority. This is what a counterparty's agent checks before it accepts an order, signs, or pays.

Principal executive officerMichael F. Mahoney, Chairman of the Board, President and Chief Executive Officer, from Mar 18, 2026
Who can authorize an agentNot assessedNo Alpha inference about signing authority or board-reserved matters is published for this record.
Not assessed
bind
AI agents registered by the companyNot registered in the public RegistryAgent Deployments, Agent Use Cases, Authority Grants, TrustChecks, Action Ledger entries and Governance Receipts live in the private enterprise overlay. They are never projected into the public Registry without explicit cross-plane authorization. Absence here is a plane boundary, not evidence that the enterprise operates no agents.
Agent registry
agents
Delegations publishedNot disclosedBoard and officer delegation resolutions are not public filings and are not published in this record.
Search scope
delegations

Financials and market context

Evidence
Index MembershipS&P 500 (SPX)
Security ListingBSX (NYSE)
Index memberships1 membership attached to a specific security and listing.Announcements, effective dates, and removals remain distinct states; Alpha does not infer membership from company size, exchange, or reputation.
SPX
Source reportedAs of Oct 16, 2026. Rights-filtered public evidence only; no redistribution or model training is granted. Only source-backed memberships with an explicit public redistribution basis are returned.
IndexSecurityStatusEffectiveVerificationSource
S&P 500 (S&P Dow Jones Indices)NYSE: BSXcurrentFeb 24, 1995inferredSlickcharts S&P 500 constituent table (public observation, not S&P DJI license)

Governance and policies

Evidence

No published claims

Nothing is published for this section yet. A missing Claim is a coverage state, not a negative finding.

Risk, audit, and cyber

Evidence

No published claims

Nothing is published for this section yet. A missing Claim is a coverage state, not a negative finding.

AI oversight and accountability

Evidence

No published claims

Nothing is published for this section yet. A missing Claim is a coverage state, not a negative finding.

Compensation

Evidence

No published claims

Nothing is published for this section yet. A missing Claim is a coverage state, not a negative finding.

Other published claims

Evidence

Published Claims that belong to no section above. Each keeps its permalink, evidence, and assertion state.

Legal NameBOSTON SCIENTIFIC CORP
Entity StatusPublic listing published
Official Websitehttps://www.bostonscientific.com
Published FactHealthcare
Published Facthttps://www.bostonscientific.com

Not yet in this record

Coverage

A gap is a coverage state, not a negative finding. These sections are expected for this entity class and are not yet published.

  • Corporate structureNot reviewed. Parent, subsidiary and predecessor structure explains who is governed.
  • OwnershipNot reviewed. Ownership and voting power determine who can influence the board.
  • FinancialsNot reviewed. Governance-relevant financial context frames capital and audit decisions.
  • CompensationNot reviewed. Pay design shows how incentives are governed.
  • GovernanceNot reviewed. Governing documents and provisions set the rules of the enterprise.
  • Shareholder governanceNot reviewed. Meeting and vote records show shareholder dissent and support.
  • AuditNot reviewed. Auditor, controls and restatements show assurance over reporting.
  • LegalNot reviewed. Material legal and regulatory matters show enforcement exposure.
  • RiskNot reviewed. Risk ownership links the board, committees, executives and controls.
  • CyberNot reviewed. Cyber and data governance is a disclosed oversight domain.
  • AI governanceNot reviewed. AI oversight is a differentiated Alpha governance domain.
  • Absence of a leadership role, committee, or disclosure is not evidence that it does not exist.Absence of a leadership role, committee, or disclosure is not evidence that it does not exist.
  • Only explicitly published canonical company identity and current confirmed public roles are included.Only explicitly published canonical company identity and current confirmed public roles are included.
  • Absence of a board, committee, executive, listing, or claim is not evidence that it does not exist.Absence of a board, committee, executive, listing, or claim is not evidence that it does not exist.
  • Public retrieval does not grant redistribution, model-training, direct-contact, or relationship-pathfinding rights.Public retrieval does not grant redistribution, model-training, direct-contact, or relationship-pathfinding rights.
  • This Company Profile is an identity and evidence record, not an Alpha rating.This Company Profile is an identity and evidence record, not an Alpha rating.

Subject and corrections

Public-role doctrine

This record exists because the company is in the published Registry. The company can claim the record, correct, or dispute any Claim. Corrections are versioned and the original stays in history.

Basis
Published company record built from public sources
Sources
10 evidence records cited. 0 with redistribution rights.
Never published
Private enterprise overlay data: deployments, authority grants, TrustChecks, receipts, telemetry
Record claimed
No
Open disputes
0
Identity ownership
unclaimed
Claiming not yet available

If the company claims the record, its statements appear as their own assertion state and never overwrite the cited evidence.

Evidence

Authority and rights
  1. E1
    Alpha canonical company public projection. canonical identity. Retrieved Oct 15, 2026. Cited by 6 Claims.
    Open web
    Rights not recorded, link only
    Evidence not pinned
  2. E2
    BOSTON SCIENTIFIC CORP Form 10-K (filed 2026-02-17). SEC filing. Retrieved Aug 29, 2026. Cited by 2 Claims.
    Authoritative, regulatory filing
    Rights not recorded, link only
    Evidence not pinned
  3. E3
    sec proxy. Published Mar 18, 2026. Retrieved Mar 21, 2026. Cited by 10 Claims.
    Authoritative, regulatory filing
    Rights not recorded, link only
    Evidence not pinned
  4. E4
    sec filing. Published Mar 18, 2026. Retrieved May 4, 2026. Cited by 1 Claim.
    Authoritative, regulatory filing
    Rights not recorded, link only
    Evidence not pinned
  5. E5
    sec filing. Published Mar 18, 2026. Retrieved May 4, 2026. Cited by 1 Claim.
    Authoritative, regulatory filing
    Rights not recorded, link only
    Evidence not pinned
  6. E6
    sec filing. Published Mar 18, 2026. Retrieved May 4, 2026. Cited by 1 Claim.
    Authoritative, regulatory filing
    Rights not recorded, link only
    Evidence not pinned
  7. E7
    sec filing. Published Mar 18, 2026. Retrieved May 4, 2026. Cited by 1 Claim.
    Authoritative, regulatory filing
    Rights not recorded, link only
    Evidence not pinned
  8. E8
    sec filing. Published Mar 18, 2026. Retrieved May 4, 2026. Cited by 1 Claim.
    Authoritative, regulatory filing
    Rights not recorded, link only
    Evidence not pinned
  9. E9
    board_seats. board seats. Cited by 22 Claims.
    Authoritative, regulatory filing
    Rights not recorded, link only
    Evidence not pinned
  10. E10
    Slickcharts S&P 500 constituent table (public observation, not S&P DJI license). index provider. Retrieved Sep 2, 2026. Cited by 1 Claim.
    Open web
    Rights not recorded, link only
    Evidence not pinned

What changed in version public-1:d751713988987e9331980363e24189ce:ro-d751713988987e9331980363e24189ce

vpublic-1:d751713988987e9331980363e24189ce:ro-d751713988987e9331980363e24189ce published Oct 15, 2026
  • Arthur C. Butcher executive of Boston Scientific, effective 2026-03-18.
  • Jonathan R. Monson executive of Boston Scientific, effective 2026-03-18.
  • Joseph M. Fitzgerald executive of Boston Scientific, effective 2026-03-18.
  • Michael F. Mahoney executive of Boston Scientific, effective 2026-03-18.
  • Vance R. Brown executive of Boston Scientific, effective 2026-03-18.
  • Cathy R. Smith seat on Boston Scientific, effective 2026-01-01.
  • Christophe P. Weber seat on Boston Scientific, effective 2026-01-01.
  • Audit; Nominating and Governance committee of Boston Scientific, effective 2026-01-01.
  • Cathy R. Smith member of Audit; Nominating and Governance, effective 2026-01-01.
  • Executive Compensation and Human Resources; Risk, Science and Technology committee of Boston Scientific, effective 2026-01-01.
  • Christophe P. Weber member of Executive Compensation and Human Resources; Risk, Science and Technology, effective 2026-01-01.
  • Cheryl Pegus seat on Boston Scientific, effective 2024-01-01.
  • David C. Habiger seat on Boston Scientific, effective 2024-01-01.
  • Audit; Executive Compensation and Human Resources committee of Boston Scientific, effective 2024-01-01.
  • David C. Habiger member of Audit; Executive Compensation and Human Resources, effective 2024-01-01.
  • Executive Compensation and Human Resources; Risk, Science and Technology · Chair committee of Boston Scientific, effective 2024-01-01.
  • Cheryl Pegus member of Executive Compensation and Human Resources; Risk, Science and Technology · Chair, effective 2024-01-01.
  • Jessica L. Mega seat on Boston Scientific, effective 2023-01-01.
  • Susan E. Morano seat on Boston Scientific, effective 2023-01-01.
  • Audit; Nominating and Governance · Chair committee of Boston Scientific, effective 2023-01-01.
  • Susan E. Morano member of Audit; Nominating and Governance · Chair, effective 2023-01-01.
  • Jessica L. Mega member of Executive Compensation and Human Resources; Risk, Science and Technology, effective 2023-01-01.
  • David S. Wichmann seat on Boston Scientific, effective 2021-01-01.
  • Audit · Chair; Risk, Science and Technology committee of Boston Scientific, effective 2021-01-01.
  • David S. Wichmann member of Audit · Chair; Risk, Science and Technology, effective 2021-01-01.
  • Ellen M. Zane seat on Boston Scientific, effective 2016-01-01.
  • Executive Compensation and Human Resources · Chair; Nominating and Governance committee of Boston Scientific, effective 2016-01-01.
  • Ellen M. Zane member of Executive Compensation and Human Resources · Chair; Nominating and Governance, effective 2016-01-01.
  • Eric Ludwig seat on Boston Scientific, effective 2014-01-01.
  • Eric Ludwig lead independent director of Boston Scientific, effective 2014-01-01.
  • Eric Ludwig member of Audit; Nominating and Governance, effective 2014-01-01.
  • Michael F. Mahoney seat on Boston Scientific, effective 2012-01-01.
Appearance

Alpha Governance PBC. The Registry records reported facts and Alpha's assessments separately. A missing fact is not evidence that it is false.

Record alpha:company:c74e3454-c7a5-426f-b315-da986196b6e2, version public-1:d751713988987e9331980363e24189ce:ro-d751713988987e9331980363e24189ce. https://registry.alpha.ac/companies/boston-scientific-corp

Navigate

esc
  • Actions
    Switch to agent viewJSON, Markdown, MCP
  • Copy Alpha IDalpha:company:c74e3454-c7a5-426f-b315-da986196b6e2
  • Cite this recordBoston Scientific
  • Copy canonical URLregistry.alpha.ac/companies/boston-scientific-corp
  • Copy as MarkdownWith assertion states
  • Report an error
  • Theme: System
  • Theme: Light
  • Theme: Dark
  • Records
    Boston ScientificCompany
  • Arthur C. ButcherPerson
  • Jonathan R. MonsonPerson
  • Joseph M. FitzgeraldPerson
  • Michael F. MahoneyPerson
  • Vance R. BrownPerson
  • Cathy R. SmithPerson
  • Cheryl PegusPerson
  • Christophe P. WeberPerson
  • David C. HabigerPerson
  • David S. WichmannPerson
  • Ellen M. ZanePerson
  • Eric LudwigPerson
  • Jessica L. MegaPerson
  • Susan E. MoranoPerson
  • Sections
    OverviewBoston Scientific
  • MonitoringBoston Scientific
  • LeadershipBoston Scientific
  • BoardBoston Scientific
  • CommitteesBoston Scientific
  • Control and votingBoston Scientific
  • Authority to actBoston Scientific
  • FinancialsBoston Scientific
  • GovernanceBoston Scientific
  • RiskBoston Scientific
  • AI oversightBoston Scientific
  • LegalBoston Scientific
  • CompensationBoston Scientific
  • Other published claimsBoston Scientific
  • Coverage gapsBoston Scientific
  • Linked peopleBoston Scientific
↑ ↓ move↵ openThis record only

Report an error

Reports attach to the Claim and go to an Alpha analyst through the correction form. Corrections are versioned, and the original stays in history.